m selective nmda receptor antagonist r cpp r 3 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
m selective nmda receptor antagonist r cpp r 3
M Selective Nmda Receptor Antagonist R Cpp R 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 167 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m+selective+nmda+receptor+antagonist+r+cpp+r+3/(R)-CPP/pmc07168262-210-117-125
Average 95 stars, based on 167 article reviews
M Selective Nmda Receptor Antagonist R Cpp R 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 167 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m+selective+nmda+receptor+antagonist+r+cpp+r+3/(R)-CPP/pmc07168262-210-117-125
Average 95 stars, based on 167 article reviews
m selective nmda receptor antagonist r cpp r 3 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Incubation:Article Title: Localized Calcium Signaling and the Control of Coupling at Cx36 Gap Junctions Article Snippet: .. Cells were incubated in CMS either alone (control) or containing 10 μ M protein kinase A antagonist Rp-8-cpt-cAMPs (Axxora LLC), 10 μ M protein kinase A agonist Sp-8-cpt-cAMPs (Axxora), 30 μ M glutamate + 1 m M glycine, or 100 μ M glutamate + 1 m M glycine for 5 min. Additional experiments investigating glutamate receptor contribution to tracer coupling employed the 100 μ M glutamate + 1 m M glycine incubation for 5 min with or without 100 n M selective kainate receptor antagonist ACET [(S)−1-(2-amino-2-carboxyethyl)−3-(2-carboxy-5-phenylthiophene-3-yl-methyl)−5-methylpyrimidine-2,4-dione; R&D Systems], 20 μ M AMPA/kainate receptor antagonist CNQX (6-cyano-7-nitroquinoxaline-2,3-dione; R&D Systems), 40 μ M AMPA and kainate receptor antagonist GYKI 53 655 (1-(4-aminophenyl)−3-methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; R&D Systems), or 20 μ Control:Article Title: Localized Calcium Signaling and the Control of Coupling at Cx36 Gap Junctions Article Snippet: .. Cells were incubated in CMS either alone (control) or containing 10 μ M protein kinase A antagonist Rp-8-cpt-cAMPs (Axxora LLC), 10 μ M protein kinase A agonist Sp-8-cpt-cAMPs (Axxora), 30 μ M glutamate + 1 m M glycine, or 100 μ M glutamate + 1 m M glycine for 5 min. Additional experiments investigating glutamate receptor contribution to tracer coupling employed the 100 μ M glutamate + 1 m M glycine incubation for 5 min with or without 100 n M selective kainate receptor antagonist ACET [(S)−1-(2-amino-2-carboxyethyl)−3-(2-carboxy-5-phenylthiophene-3-yl-methyl)−5-methylpyrimidine-2,4-dione; R&D Systems], 20 μ M AMPA/kainate receptor antagonist CNQX (6-cyano-7-nitroquinoxaline-2,3-dione; R&D Systems), 40 μ M AMPA and kainate receptor antagonist GYKI 53 655 (1-(4-aminophenyl)−3-methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; R&D Systems), or 20 μ |